Introduction
Insulin-like growth factors (IGF-I and -II) play an important role in stimulating the synthesis of cartilage's extracelluar matrix (ECM) [1] , counteracting 'catabolic agents' that result in tissue degradation [2, 3] . As experiments have shown that chondrocytes synthesize little or no IGF-I under the culture conditions [1] , it is reasonable to assume that the majority of IGF-I in cartilage is supplied from synovial fluid. However, IGFs must be transported into the cartilage from synovial fluid through the processes of diffusion and advection, before they can exert their A family of six IGF binding proteins (IGFBPs) regulate IGF activity [2, [6] [7] [8] . In vivo,
IGF-I and -II competitively bind to these six IGFBPs simultaneously, but with differential affinities. The measurements of the interaction kinetics between IGFs and their binding proteins in solutions showed that IGFBPs 1-5 have a similar binding preference for IGF-I and -II (although IGFBP-2 has a slight IGF-II binding preference), whereas the IGFBP-6 differs from other binding proteins in that it displays a 20 to 100 fold higher affinity for IGF-II than IGF-I [7, [9] [10] [11] [12] . To constrain the complete set of possible interactions, as an approximation we study the interaction of the six IGFBPs with the IGF-I and -II by considering two IGFBP functional groupings. That is, one group has similar binding affinity for IGF-I and II (i.e. IGFBPs 1-5), whereas the second group has a significantly higher binding preference for IGF-II compared to IGF-I (i.e. IGFBP-6).
The second objective of this study is to conduct a series of computational experiments by varying boundary conditions of IGFs and the ratio of two IGFBP functional groups according to various cartilage conditions. In diseased cartilage, such as osteoarthritis and rheumatoid arthritis as examples, the level of IGF-I in arthritic synovial fluid is found to be increased relative to normal cartilage [13] . It has also been noticed that there is a significant increase in content of IGFBPs in diseased cartilage, especially IGFBP-3 [14] . Furthermore, IGFBP content in cartilage has been shown to differ from species to species. For example, although large amount of IGFBP-6 was identified in bovine cartilage [15] , but it has been reported that the level of IGFBP-6 was too low to detect in human cartilage [14] . All these changes may have a significant impact on IGF-I uptake by the cartilage, and so are worthy of further investigation.
Physiological relevant mechanical loading has been theoretically demonstrated to enhance the IGF transport through advective fluid flow [16, 17] . Our previous study [18] demonstrated that IGFBPs are essential for enhancing the uptake of IGF into cartilage. It is likely though, that under physiological conditions, the presence of IGF-II in synovial fluid and the competitive binding of IGF-I and -II to their IGFBPs will modify the advective transport behavior of IGFs. The current study further investigates the combined effect of cyclic loading and competitive binding on IGF uptake into cartilage tissue.
Governing Equations
To describe solute transport in a deforming cartilage, a porous media model is often employed [17, [19] [20] [21] . The porous media continuum approach treats the articular cartilage as a where subscript i refers to each group of IGFBPs, and subscript j =1 refers to IGF-I and j = 2 to IGF-II. 
Conservation of mass

Conservation
which describes solute transport by diffusion and advection in a deforming porous media.
The conservation of mass of solid and fluid phase in the REV leads to a governing equation linking the cartilage matrix deformation to interstitial fluid motion [16, 18] .
where s v is solid phase velocity, κ the hydraulic permeability tensor, and p the interstitial fluid pressure. Using Eq. (3.10), we can simplify the Eq. (3.9) after some algebraic manipulations [18] (
Eq. (3.11) is the governing transport equation for IGF-I and -II. The mechanical quantities, such as fluid pressure, displacement and velocity can be determined using methods presented in our previous studies [16, 18] .
The Law of mass action
The Assuming no net change of IGFBPs on the timescale of transport experiment, the chemical reactions involving IGFs and two groups of IGFBs are described mathematically using the Law of Mass Action [23] [24] [25] . That is, it is assumed that the reaction rate is directly proportional to the product of the effective volume-based concentrations of each participating molecule. These assumptions lead to the following simultaneous equations.
( ) . We find, 
These turn out to be a pair of competitive Langmuir sorption isotherms [24] . The total growth factor uptake ratio ( ui R ) can be expressed as the sum of mobile (free) solute uptake (
and bound (complexed) solute uptake ( 
Results and Discussion
The values of parameters estimated by the optimization process are shown in Table 1 .
The estimates of 
Theoretical prediction of growth factor transport in cartilage
Consistent with previous experimental and theoretical protocols for the study of solute transport in cartilage [16] [17] [18] , we first study the radial solute transport into a cylindrical cartilage disk under free diffusion, and later the solute transport within a cartilage disk under unconfined cyclic compression is also explored. The governing equations in cylindrical coordinates [18] are solved numerically using the commercial Finite Element software FEMLAB [27] . Parameters given in Table 1 -2 are adopted to enable direct comparison with our previous works [16, 18] . To Since the solute concentration is generally non-uniform in the radial direction, it is useful to define the average total IGF uptake ratio ( ui R ) as the sum of average free IGF uptake ratio Due to the avascular nature of cartilage, IGFs must diffuse or be advected into the cartilage to interact with chondrocytes. The major source of circulating IGF-I is from liver, whereas IGF-II in cartilage is likely contributed by many tissues including brain, bone and muscle. [29] . The immediate source of the IGFs found in articular cartilage is believed to be from synovial fluid [22] . In normal human synovial fluid, the concentration of IGF-I is much lower than that of IGF-II [13] . By setting boundary conditions to that observed in human synovial fluid [13, 22, 30] , we see that competitive binding leads to a relatively higher free IGF-I uptake within the cartilage compared to predictions based on a model that neglects competitive binding by IGF-II (around 6%) as shown in Figure 2a . As experimental studies [1, 31] suggested that the biosynthesis of matrix molecules can be rapidly "switched on" when IGF-I concentration 
The parametric studies
In human OA cartilage, it has been found that IGF-I concentration in synovial fluid, as well as the IGFBP content in cartilage, differ from normal physiological state [13, 14] . The effect of these changes on free IGF-I uptake within the cartilage is relatively difficult to quantify in experiments, either in vitro or in vivo. For this reason, the purpose of current parametric study is to conduct a series of 'mathematical experiments' to understand the bioavailability of free IGF-I under various cartilage conditions.
Both free IGF-I and -II influence cartilage biosynthesis. However, IGF-II is less potent than IGF-I, for example, the effects of 100ng/ml IGF-II on cartilage biosynthesis was found only about 60% of those for 5 ng/ml IGF-I [1] . According to experimental reports [13] , there is a significant increase in the total IGF-I level in human synovial fluid in both osteoarthritis and rheumatoid arthritis patients in comparison with normal cartilage (e.g. increasing from 20 to 80ng/ml [13] ), but no change in the level of IGF-II. In Figure 3 in diseased cartilage may lead to a decrease of free IGF-I concentration. This numerical prediction is supported by experimental studies [33, 35] suggesting that the synthesis of IGFBPs limits the presence of free IGF-I in the cartilage tissue, thus inhibiting its anabolic action. Hence the current study underlines the importance of considering the cartilage as a system, with multiple interacting components. It should be mentioned here that to simplify the problem, this study ignores the possible IGFindependent effects of IGFBPs suggested by Mohan et al, 2002 [29] . Clearly additional systems need to be included in the model, and so the predictions made here must necessarily be considered provisional.
The content of IGFBPs in cartilage varies between species. Although previous work had identified large amounts of IGFBP-6 in bovine cartilage extracts using quantitative Western ligand blots [15] , IGFBP-6 has not been detected in human cartilage so far using the same in articular cartilage, and why does it vary between species? Our future studies will address these questions.
Diffusion with cyclic deformation
The model developed here can also be used to explore the combined effects of cyclic compression and competitive binding on IGF uptake. Here the dynamic compression is applied under strain control, assuming 0 ε is the peak-to-peak strain amplitude and f is the loading frequency, then
Our previous study [18] examined the effect of solute binding on IGF-I transport in a cyclically deformed cartilage. It was demonstrated that IGFBPs enhanced IGF-I uptake by the cartilage. To further understand the effect of competitive binding in combination with cyclic loading, the uptake of IGF-I in cartilage subjected to 5 hour 0.1 Hz and 6% strain dynamic compression is considered. Figure 6 shows cyclic loading significantly enhances both free and complexed IGF-I uptake, however, it is noted that the enhancement is considerably exaggerated if the competitive binding is ignored in the model.
Conclusion
In this study, we have developed a poromechanical continuum transport model coupled with the second order competitive binding model of IGFs, and employed this model to describe growth factor uptake by cartilage. The results demonstrated that by modeling the IGFBP as two functional groups, the distinctive experimental binding outcomes of Bhakta et al's experiment [4] can be described using reversible competitive Langmuir sorption models. Moreover, this sorption model suggests that the availability of free IGF-I in the cartilage is mainly regulated by IGFBPs 1-5, while IGFBP-6 appears to have little influence due to its relatively low binding affinity to IGF-I.
The model parameters, such as IGF concentration at cartilage surface, and ratio of two functional IGFBP groups, are then examined so as to investigate the growth factor transport behavior for various cartilage conditions. A summary of main findings are:
• The numerical results show that ignoring competitive binding results in an underestimation of the rate of free IGF-I uptake, but an overestimation of complexed IGF uptake, and prolongs the time for total IGF-I to reach equilibrium. The biological implication of these findings is that competitive binding may increase the bioavailability of IGF-I by reducing the transport inhibiting effect of IGFBPs, while still provide a store of IGFs.
• The increase of IGF-I level at cartilage surface leads to a greater rate of free IGF-I uptake in the cartilage, however, the increase of the first IGFBP functional group (i.e. IGFBPs 1-5) significantly decreases the rate of free IGF-I uptake.
• Dynamic compression enhances the rate of free IGF-I uptake; however, this enhancement is exaggerated if the competitive binding is ignored.
Articular cartilage is a complex tissue, and so should be considered from a systems 
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